{
  "trial_id": "NCT01421667",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race, ECOG performance status, prior lines of therapy, disease stage, CD30 expression level, histological subtype, measurable disease size, duration of disease, prior treatments received.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Eastern Cooperative Oncology Group Performance Status (ECOG)",
          "ECOG performance status"
        ],
        [
          "Disease Stage",
          "disease stage"
        ],
        [
          "% CD30 Expression by Visual Immunohistochemistry (vIHC)",
          "CD30 expression level"
        ],
        [
          "Pathological Diagnosis",
          "histological subtype"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Transformed Disease from Prior Non-Hodgkin Lymphoma",
        "Bulky Disease (\u22655 cm on at least one baseline index lesion)",
        "Refractory to Frontline Therapy",
        "Disease Status Relative to Most Recent Prior Therapy"
      ],
      "remaining_candidate_features": [
        "prior lines of therapy",
        "measurable disease size",
        "duration of disease",
        "prior treatments received"
      ]
    },
    "processed-gen-response": "Age, gender, race, ECOG performance status, prior lines of therapy, disease stage, CD30 expression level, histological subtype, measurable disease size, duration of disease, prior treatments received."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, ECOG performance status, Histological subtype of NHL, Number of prior systemic therapies, Measurable disease size,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Eastern Cooperative Oncology Group Performance Status (ECOG)",
          "ECOG performance status"
        ],
        [
          "Pathological Diagnosis",
          "Histological subtype of NHL"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Transformed Disease from Prior Non-Hodgkin Lymphoma",
        "Disease Stage",
        "Bulky Disease (\u22655 cm on at least one baseline index lesion)",
        "% CD30 Expression by Visual Immunohistochemistry (vIHC)",
        "Refractory to Frontline Therapy",
        "Disease Status Relative to Most Recent Prior Therapy"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Number of prior systemic therapies",
        "Measurable disease size"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, ECOG performance status, Histological subtype of NHL, Number of prior systemic therapies, Measurable disease size"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Histological subtype of NHL, Number of prior systemic therapies, Time since last therapy, Presence of B symptoms, Ann Arbor stage, LDH level, Bone marrow involvement, Extranodal involvement, CD30 expression level.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Eastern Cooperative Oncology Group Performance Status (ECOG)",
          "ECOG Performance Status"
        ],
        [
          "Pathological Diagnosis",
          "Histological subtype of NHL"
        ],
        [
          "% CD30 Expression by Visual Immunohistochemistry (vIHC)",
          "CD30 expression level"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Transformed Disease from Prior Non-Hodgkin Lymphoma",
        "Disease Stage",
        "Bulky Disease (\u22655 cm on at least one baseline index lesion)",
        "Refractory to Frontline Therapy",
        "Disease Status Relative to Most Recent Prior Therapy"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Number of prior systemic therapies",
        "Time since last therapy",
        "Presence of B symptoms",
        "Ann Arbor stage",
        "LDH level",
        "Bone marrow involvement",
        "Extranodal involvement"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, ECOG Performance Status, Histological subtype of NHL, Number of prior systemic therapies, Time since last therapy, Presence of B symptoms, Ann Arbor stage, LDH level, Bone marrow involvement, Extranodal involvement, CD30 expression level."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, ECOG performance status, histological subtype of NHL, number of prior systemic therapies, time since last therapy, presence of B symptoms, lactate dehydrogenase (LDH) level, beta-2 microglobulin level, CD30 expression level, bulky disease status, presence of extranodal involvement.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Eastern Cooperative Oncology Group Performance Status (ECOG)",
          "ECOG performance status"
        ],
        [
          "Pathological Diagnosis",
          "histological subtype of NHL"
        ],
        [
          "% CD30 Expression by Visual Immunohistochemistry (vIHC)",
          "CD30 expression level"
        ],
        [
          "Bulky Disease (\u22655 cm on at least one baseline index lesion)",
          "bulky disease status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Transformed Disease from Prior Non-Hodgkin Lymphoma",
        "Disease Stage",
        "Refractory to Frontline Therapy",
        "Disease Status Relative to Most Recent Prior Therapy"
      ],
      "remaining_candidate_features": [
        "number of prior systemic therapies",
        "time since last therapy",
        "presence of B symptoms",
        "lactate dehydrogenase (LDH) level",
        "beta-2 microglobulin level",
        "presence of extranodal involvement"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, ECOG performance status, histological subtype of NHL, number of prior systemic therapies, time since last therapy, presence of B symptoms, lactate dehydrogenase (LDH) level, beta-2 microglobulin level, CD30 expression level, bulky disease status, presence of extranodal involvement."
  }
}